Urology Practices
Sell Your Urology Practice to a Buyer Who Gets the Model
Urology practices combine surgical care with high-value ancillary services like in-house pathology and imaging that most buyers don’t fully understand. We help you get a valuation that reflects that complexity, and find a buyer who will protect care continuity for your patients.
Market Snapshot
Ancillary Services Define a Heavily Consolidated Field
Urology practice sales don’t follow the same playbook as other specialties. A few things make this market distinct.
Urology Is a Leading PE Consolidation Target
Alongside dermatology and ophthalmology, urology has seen some of the most active private equity roll-up activity in medicine, driven largely by its ancillary revenue potential.
In-House Pathology and Imaging Drive Value
Practices with in-office pathology, ultrasound, and radiation therapy capabilities generate revenue streams well beyond standard office visits, and buyers price this capability heavily.
Robotic Surgery Volume Shapes Buyer Interest
Practices with established robotic surgery programs attract stronger buyer interest, since this capability drives both surgical revenue and referral volume.
Valuation
Three Things That Move Urology Practice Value
Ancillary & Pathology Revenue
In-house pathology, imaging, and radiation therapy capabilities add durable revenue that’s harder for a buyer to replicate.
Surgical & Procedural Volume
Robotic surgery, in-office procedures like cystoscopy and vasectomy, and lithotripsy volume each contribute differently to how buyers value a practice.
Subspecialty Mix
Uro-oncology, female urology, and men’s health each carry different referral patterns and reimbursement profiles, shaping how buyers evaluate a practice.
Buyer Landscape
Understanding Your Buyer Pool
Because ancillary operations and surgical volume carry real weight in urology, we help you understand not just what each buyer will pay, but how they tend to run a practice — and support its patients — after close.
| Buyer Type | What They're Looking For |
|---|---|
| Private equity–backed urology platforms | Multi-site groups with strong ancillary and pathology revenue, and room to standardize operations across locations. |
| Health systems & multi-specialty groups | Practices that strengthen urologic and oncology service lines and referral networks within their existing footprint. |
| Individual urologists | Solo or small practices, often prioritizing patient continuity and clinical culture as much as price. |
Our Process
How We Approach a Urology Practice Sale
01
Confidential Consultation
Understanding your service mix, ancillary capabilities, and what continuity means to you.
02
Specialty Valuation
Accounting for ancillary/pathology revenue, surgical volume, and subspecialty mix.
03
Confidential Marketing
Preparing a confidential executive summary and readying your practice for the market.
04
Buyer Vetting & Offers
Introducing vetted buyers and evaluating how each plans to support your patients and clinical team.
05
Negotiation & Diligence
Navigating diligence, including in-house lab/pathology compliance, Stark law self-referral considerations, and payer contracts.
06
The Handoff
A transition plan built to keep patients, providers, and referral sources intact
Proof
Our Track Record
85%
of engagements reach close
80+
combined years of healthcare-specific brokerage experience
95%
of clients land within 10% of expected valuation
FAQ
Common Questions
Will my patients keep seeing the same providers after a sale?
In most transitions, yes — buyers acquiring a urology practice are typically buying the physician team along with the patient panel, since continuity matters for patients managing ongoing conditions like prostate cancer surveillance. We prioritize buyers who plan to retain your providers, and we build retention terms into the deal structure wherever possible.
How does my in-house pathology or imaging program affect my valuation?
In-house pathology and imaging capabilities are typically viewed as high-value, high-margin revenue streams that are difficult for a buyer to replicate without matching infrastructure. We help you document this revenue clearly — including compliance with self-referral regulations — so buyers price it as the distinct asset it is.
Does having a robotic surgery program add value to my practice?
Yes — an established robotic surgery program signals strong surgical volume and often drives referral relationships beyond what a practice without one can achieve. We help you present your surgical case volume and outcomes clearly, so buyers can see the full strength of your surgical program rather than judging the practice on office visits alone.